Use of mesenchymal stromal cells derived from the Wharton's jelly of human umbilical cord for treating patients with steroid-resistant graft versus host disease: predicting clinical response by a validated immunopotency assay.

Torrents S, García-Buendía A, Codinach M, Rodríguez L, Marsal Ricomà J, Del Trabazo Del Castillo M, Díaz de Heredia C, Pérez-Torres Lobato MR, López Torija I, Mussetti A, López Cadenas F, Peña Domingo M, Castillo-Flores N, Querol S, Vives J

Open source

DOI: 10.1038/s41598-026-58936-7
Published: 2026 Jun 22
Container: Scientific reports
Publisher: Not recorded
Open access: yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
supportingDirectory of Open Access Journals: A matching record was returned by DOAJ. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1038/s41598-026-58936-7,
  title = {Use of mesenchymal stromal cells derived from the Wharton's jelly of human umbilical cord for treating patients with steroid-resistant graft versus host disease: predicting clinical response by a validated immunopotency assay.},
  author = {Torrents S and García-Buendía A and Codinach M and Rodríguez L and Marsal Ricomà J and Del Trabazo Del Castillo M and Díaz de Heredia C and Pérez-Torres Lobato MR and López Torija I and Mussetti A and López Cadenas F and Peña Domingo M and Castillo-Flores N and Querol S and Vives J},
  year = {2026},
  journal = {Scientific reports},
  doi = {10.1038/s41598-026-58936-7},
  url = {https://doi.org/10.1038/s41598-026-58936-7}
}

RIS

TY  - JOUR
TI  - Use of mesenchymal stromal cells derived from the Wharton's jelly of human umbilical cord for treating patients with steroid-resistant graft versus host disease: predicting clinical response by a validated immunopotency assay.
AU  - Torrents S
AU  - García-Buendía A
AU  - Codinach M
AU  - Rodríguez L
AU  - Marsal Ricomà J
AU  - Del Trabazo Del Castillo M
AU  - Díaz de Heredia C
AU  - Pérez-Torres Lobato MR
AU  - López Torija I
AU  - Mussetti A
AU  - López Cadenas F
AU  - Peña Domingo M
AU  - Castillo-Flores N
AU  - Querol S
AU  - Vives J
PY  - 2026
JO  - Scientific reports
DO  - 10.1038/s41598-026-58936-7
UR  - https://doi.org/10.1038/s41598-026-58936-7
ER  -

APA

S, T., A, G., M, C., L, R., J, M. R., M, D. T. D. C., C, D. D. H., MR, P. L., I, L. T., A, M., F, L. C., M, P. D., N, C., S, Q., & J, V. (2026). Use of mesenchymal stromal cells derived from the Wharton's jelly of human umbilical cord for treating patients with steroid-resistant graft versus host disease: predicting clinical response by a validated immunopotency assay.. Scientific reports. https://doi.org/10.1038/s41598-026-58936-7

Source records

pubmed · retrieved 2026-09-26T12:57:50.431Z
europe-pmc · retrieved 2026-09-26T12:57:50.437Z
doaj · retrieved 2026-09-26T12:57:50.400Z